Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Non-Current Assets: 2022-2023

Historic Non-Current Assets for Therapeutics (LENZ) over the last 2 years, with Sep 2023 value amounting to $27.4 million.

  • Therapeutics' Non-Current Assets fell 24.50% to $27.4 million in Q3 2023 from the same period last year, while for Sep 2023 it was $27.4 million, marking a year-over-year decrease of 24.50%. This contributed to the annual value of $46.5 million for FY2022, which is N/A change from last year.
  • Per Therapeutics' latest filing, its Non-Current Assets stood at $27.4 million for Q3 2023, which was down 23.49% from $35.9 million recorded in Q2 2023.
  • In the past 5 years, Therapeutics' Non-Current Assets ranged from a high of $46.5 million in Q4 2022 and a low of $27.1 million during Q2 2022.
  • In the last 2 years, Therapeutics' Non-Current Assets had a median value of $35.9 million in 2023 and averaged $35.4 million.
  • The largest annual percentage gain for Therapeutics' Non-Current Assets in the last 5 years was 32.17% (2023), contrasted with its biggest fall of 24.50% (2023).
  • Quarterly analysis of 2 years shows Therapeutics' Non-Current Assets stood at $46.5 million in 2022, then fell by 24.50% to $27.4 million in 2023.
  • Its Non-Current Assets was $27.4 million in Q3 2023, compared to $35.9 million in Q2 2023 and $39.7 million in Q1 2023.